<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00454311</url>
  </required_header>
  <id_info>
    <org_study_id>VLC-CR-1106-307-5</org_study_id>
    <nct_id>NCT00454311</nct_id>
  </id_info>
  <brief_title>The Impact of the Biopsy of 1-2 Cells in a PGD Program for Anueploidy Screening</brief_title>
  <official_title>Prospective and Randomized Study of the Impact of the Biopsy of 1-2 Cells in a PGD Program for Aneuploidy Screening</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Valenciano de Infertilidad, IVI VALENCIA</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto Valenciano de Infertilidad, IVI VALENCIA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the impact of the biopsy of one or two cells in a
      preimplantatation genetic diagnosis program (PGD) for the screening of aneuploidies. This
      prospective and randomized study will be performed at the Instituto Valenciano de
      Infertilidad in Valencia (Spain) in those patientes included in our clinical program. Our
      purpose is to optimize the methodology employed in our laboratory in order to guarantee
      optimal implantation and pregnancy rates without a detrimental effect on the accuracy and
      efficiency of the cytogenetic analysis. Patients will undergo and IVF cycle, embryo biopsy
      will be performed on day 3 embryos in two fashions: in some patients only one cell per embryo
      will be retrieved whereas in others, 2 cells will be retrieved in good morphology embryos and
      only 1 in the slowl ones. In all cases aneuploidy screening will be performed by FISH for
      chromosomes 13, 16, 18, 21, 22, X and Y. Embryo developmente will be checked every 24 hours
      and chormosomally normal embryos will be replaced into the uterus on day 5 of development.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>impact of biopsy</measure>
    <time_frame>8 days</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>One cell biopsy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Two cell biopsy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Biopsy of Day 3 Embryo</intervention_name>
    <arm_group_label>Two cell biopsy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Â· day embryo biopsy</intervention_name>
    <arm_group_label>One cell biopsy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing PGD for aneuploidy screening with their own oocytes and for
             chromosomes 13, 16, 18, 21, 22, X &amp; Y

        Exclusion Criteria:

          -  Patients undergoing PGD for monogenic diseases (PCR)

          -  Patients undergoing PGD for structural chromosomal abnormalities

          -  Ovum donation cycles

          -  Cryopreserved oocyte/embryos
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carmen Rubio, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto Valenciano de Infertilidad</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Instituto Valenciano de la Infertilidad</name>
      <address>
        <city>Valencia</city>
        <zip>46015</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>March 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 29, 2007</study_first_submitted>
  <study_first_submitted_qc>March 29, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 30, 2007</study_first_posted>
  <last_update_submitted>March 3, 2011</last_update_submitted>
  <last_update_submitted_qc>March 3, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 4, 2011</last_update_posted>
  <responsible_party>
    <name_title>Dr. Carmen Rubio</name_title>
    <organization>IVI Valencia</organization>
  </responsible_party>
  <keyword>Pregnancy and implantation rates</keyword>
  <keyword>Efficiency and accuracy of the genetic testing</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

